BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29046615)

  • 1. Integrated genomic characterization of cancer genes in glioma.
    Liang A; Zhou B; Sun W
    Cancer Cell Int; 2017; 17():90. PubMed ID: 29046615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes.
    Zhang Z; Xu L; Sun C
    Oncol Lett; 2018 Feb; 15(2):1503-1510. PubMed ID: 29434842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
    Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
    Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of driver genes in diffuse large B cell lymphoma.
    Fan Z; Pei R; Sha K; Chen L; Wang T; Lu Y
    Oncol Lett; 2020 Jul; 20(1):382-390. PubMed ID: 32565964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
    Li J; Guo L; Chai L; Ai Z
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830966. PubMed ID: 30852945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated analysis of cancer genes in clear cell renal cell carcinoma.
    Li J; Guo L; Ai Z
    Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma.
    Xie J; Lin Y; Li Y; Fang A; Li X; Wang S; Li W
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
    Wang H; Shen L; Li Y; Lv J
    J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated analysis of cancer genes in thyroid cancer.
    Chai L; Li J; Lv Z
    Oncol Rep; 2016 Feb; 35(2):962-70. PubMed ID: 26718127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes.
    Dong C; Guo Y; Yang H; He Z; Liu X; Wang K
    Genome Med; 2016 Dec; 8(1):135. PubMed ID: 28007024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients.
    Li H; Shan C; Wu S; Cheng B; Fan C; Cai L; Chen Y; Shi Y; Liu K; Shao Y; Zhu D; Li Z
    Front Oncol; 2020; 10():607429. PubMed ID: 33747896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant Prognostic Features and Patterns of Somatic
    Zhang W; Edwards A; Flemington EK; Zhang K
    Cancer Inform; 2017; 16():1176935117691267. PubMed ID: 28469388
    [No Abstract]   [Full Text] [Related]  

  • 14. PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas.
    Noorani I; de la Rosa J; Choi YH; Strong A; Ponstingl H; Vijayabaskar MS; Lee J; Lee E; Richard-Londt A; Friedrich M; Furlanetto F; Fuente R; Banerjee R; Yang F; Law F; Watts C; Rad R; Vassiliou G; Kim JK; Santarius T; Brandner S; Bradley A
    Genome Biol; 2020 Jul; 21(1):181. PubMed ID: 32727536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.
    Sun S; Du W; Sun Q; Zhao X; Qin B; Shi D; Wan C; Wu Z
    Cancer Med; 2021 Oct; 10(20):7360-7372. PubMed ID: 34599863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
    Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
    Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.
    Xie Y; Tan Y; Yang C; Zhang X; Xu C; Qiao X; Xu J; Tian S; Fang C; Kang C
    Cancer Biol Med; 2019 Nov; 16(4):784-796. PubMed ID: 31908895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
    Huang Q; Zhou Y; Wang B; Zhao Y; Zhang F; Ding B
    BMC Med Genomics; 2022 Jul; 15(1):146. PubMed ID: 35778737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
    Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.